Cargando…
India’s cost-effective COVID-19 vaccine development initiatives
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574682/ https://www.ncbi.nlm.nih.gov/pubmed/33129610 http://dx.doi.org/10.1016/j.vaccine.2020.10.056 |
| _version_ | 1783597672859435008 |
|---|---|
| author | Chakraborty, Chiranjib Agoramoorthy, Govindasamy |
| author_facet | Chakraborty, Chiranjib Agoramoorthy, Govindasamy |
| author_sort | Chakraborty, Chiranjib |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7574682 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75746822020-10-21 India’s cost-effective COVID-19 vaccine development initiatives Chakraborty, Chiranjib Agoramoorthy, Govindasamy Vaccine Commentary Elsevier Ltd. 2020-11-25 2020-10-20 /pmc/articles/PMC7574682/ /pubmed/33129610 http://dx.doi.org/10.1016/j.vaccine.2020.10.056 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Commentary Chakraborty, Chiranjib Agoramoorthy, Govindasamy India’s cost-effective COVID-19 vaccine development initiatives |
| title | India’s cost-effective COVID-19 vaccine development initiatives |
| title_full | India’s cost-effective COVID-19 vaccine development initiatives |
| title_fullStr | India’s cost-effective COVID-19 vaccine development initiatives |
| title_full_unstemmed | India’s cost-effective COVID-19 vaccine development initiatives |
| title_short | India’s cost-effective COVID-19 vaccine development initiatives |
| title_sort | india’s cost-effective covid-19 vaccine development initiatives |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574682/ https://www.ncbi.nlm.nih.gov/pubmed/33129610 http://dx.doi.org/10.1016/j.vaccine.2020.10.056 |
| work_keys_str_mv | AT chakrabortychiranjib indiascosteffectivecovid19vaccinedevelopmentinitiatives AT agoramoorthygovindasamy indiascosteffectivecovid19vaccinedevelopmentinitiatives |